IBEX Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-96
Closed -$6K 216
2021
Q3
$6K Buy
+96
New +$6.32K ﹤0.01% 382
2021
Q2
Sell
-89,983
Closed -$5.68M 186
2021
Q1
$5.68M Sell
89,983
-2,202
-2% -$137K 1.4% 17
2020
Q4
$5.72M Buy
92,185
+630
+0.7% +$38.7K 1.49% 19
2020
Q3
$5.52M Buy
91,555
+6,118
+7% +$368K 1.6% 17
2020
Q2
$5.02M Sell
85,437
-4,531
-5% -$271K 1.61% 17
2020
Q1
$5.01M Buy
89,968
+26,040
+41% +$1.59M 1.95% 10
2019
Q4
$4.1M Buy
+63,928
New +$3.66M 1.26% 25
2017
Q1
Sell
-65
Closed -$3K 106
2016
Q4
$3K Buy
+65
New +$3.55K ﹤0.01% 411

Other funds holding BMY

IBEX Wealth Advisors's BMY Position: Q4 2021 in Review

IBEX Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 96 shares — an estimated $6K sold.

IBEX Wealth Advisors first reported a position in BMY in Q4 2016 and held it in 8 quarters. The position peaked at $5.72M in Q4 2020. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • IBEX Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • IBEX Wealth Advisors sold 96 Bristol-Myers Squibb shares in Q4 2021, an estimated $6K.
  • IBEX Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 8 quarters.
  • IBEX Wealth Advisors's Bristol-Myers Squibb position peaked at $5.72M in Q4 2020.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on IBEX Wealth Advisors's 13F filing for Q4 2021, filed 22 Feb 2022.